RxDoctor Payments Data

Marcia Haught, DO

Family Medicine · Glen Dale, WVNPI 1568783702

Payments from drug & device makers

$2,124in general payments, 2019–2025

Across 166 payments — averaging $12.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$989
  • Lilly USA, LLC$251
  • Pfizer$176
  • GSK$154
  • AbbVie$120
  • Amgen$97
  • plus $337 from 11 others

What the payments were for

  • Food & beverage$2,07498%
  • Education$512%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,124 in reported general payments places this provider in the 80th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$50,376
Medicare patients
176
Services billed
518

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide119$134,583
EliquisApixaban84$73,262
Trelegy ElliptaFluticasone/Umeclidin/Vilanter70$55,664
TrulicityDulaglutide23$36,634
XareltoRivaroxaban38$28,580
JardianceEmpagliflozin21$26,516
Tresiba Flextouch U-200Insulin Degludec33$25,590
JanuviaSitagliptin Phosphate24$16,777
FarxigaDapagliflozin Propanediol19$15,795
LinzessLinaclotide26$13,956
Potassium Chloride265$12,402
Combivent RespimatIpratropium/Albuterol Sulfate14$9,559
Breo ElliptaFluticasone/Vilanterol15$9,057
Dexlansoprazole DrDexlansoprazole39$7,002
DapagliflozinDapagliflozin Propanediol12$6,953

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$989$134,583119 claims
PfizerEliquis$176$73,26284 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$154$71,28698 claims
Lilly USA, LLCTrulicity$251$36,63423 claims
Boehringer IngelheimJardiance, Combivent Respimat$70$36,07535 claims
Johnson & JohnsonXarelto$38$28,58038 claims
MerckJanuvia$11$16,77724 claims
AstraZenecaFarxiga$66$15,79519 claims
AbbVieLinzess$120$13,95626 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Glen Dale

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →